JP2022523045A5 - - Google Patents
Info
- Publication number
- JP2022523045A5 JP2022523045A5 JP2021543165A JP2021543165A JP2022523045A5 JP 2022523045 A5 JP2022523045 A5 JP 2022523045A5 JP 2021543165 A JP2021543165 A JP 2021543165A JP 2021543165 A JP2021543165 A JP 2021543165A JP 2022523045 A5 JP2022523045 A5 JP 2022523045A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- subject
- administered
- approximately
- treated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962797854P | 2019-01-28 | 2019-01-28 | |
| US62/797,854 | 2019-01-28 | ||
| PCT/US2020/014953 WO2020159822A1 (en) | 2019-01-28 | 2020-01-24 | Methods of treating breast cancer with tucatinib |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022523045A JP2022523045A (ja) | 2022-04-21 |
| JP2022523045A5 true JP2022523045A5 (https=) | 2023-02-02 |
Family
ID=69740562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543165A Pending JP2022523045A (ja) | 2019-01-28 | 2020-01-24 | ツカチニブを用いて乳がんを処置する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220193076A1 (https=) |
| EP (1) | EP3917533A1 (https=) |
| JP (1) | JP2022523045A (https=) |
| KR (1) | KR20210119498A (https=) |
| CN (1) | CN113613656A (https=) |
| AR (1) | AR119681A1 (https=) |
| AU (1) | AU2020215551A1 (https=) |
| CA (1) | CA3126279A1 (https=) |
| IL (1) | IL284850A (https=) |
| MX (1) | MX2021008834A (https=) |
| SG (1) | SG11202107488PA (https=) |
| TW (1) | TW202042820A (https=) |
| WO (1) | WO2020159822A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019022280A2 (pt) | 2017-04-28 | 2020-05-19 | Seattle Genetics Inc | tratamento de cânceres de her2 positivo |
| US20220125877A1 (en) * | 2019-07-10 | 2022-04-28 | Sun Yat-Sen University | Method for treating colorectal cancer |
| EP4217400A1 (en) * | 2020-09-28 | 2023-08-02 | Seagen Inc. | Methods of treating solid tumors driven by her2 alterations with tucatinib in combination with an anti-her2 antibody |
| BR112023018676A2 (pt) | 2021-03-18 | 2023-10-10 | Seagen Inc | Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco |
| CN117919249A (zh) * | 2022-10-13 | 2024-04-26 | 山东大学 | 治疗骨质疏松的方法和药物组合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4957735A (en) | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| US4902505A (en) | 1986-07-30 | 1990-02-20 | Alkermes | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5004697A (en) | 1987-08-17 | 1991-04-02 | Univ. Of Ca | Cationized antibodies for delivery through the blood-brain barrier |
| US5055303A (en) | 1989-01-31 | 1991-10-08 | Kv Pharmaceutical Company | Solid controlled release bioadherent emulsions |
| US5271961A (en) | 1989-11-06 | 1993-12-21 | Alkermes Controlled Therapeutics, Inc. | Method for producing protein microspheres |
| US5188837A (en) | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
| US5268164A (en) | 1990-04-23 | 1993-12-07 | Alkermes, Inc. | Increasing blood-brain barrier permeability with permeabilizer peptides |
| US5254342A (en) | 1991-09-30 | 1993-10-19 | University Of Southern California | Compositions and methods for enhanced transepithelial and transendothelial transport or active agents |
| DE69311538D1 (de) | 1992-03-12 | 1997-07-17 | Alkermes Inc | Acth enthaltende mikrokugeln mit gesteuerter abgabe |
| US5534496A (en) | 1992-07-07 | 1996-07-09 | University Of Southern California | Methods and compositions to enhance epithelial drug transport |
| US5514670A (en) | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
| BR112019022280A2 (pt) * | 2017-04-28 | 2020-05-19 | Seattle Genetics Inc | tratamento de cânceres de her2 positivo |
-
2020
- 2020-01-21 TW TW109102121A patent/TW202042820A/zh unknown
- 2020-01-24 WO PCT/US2020/014953 patent/WO2020159822A1/en not_active Ceased
- 2020-01-24 KR KR1020217027147A patent/KR20210119498A/ko not_active Withdrawn
- 2020-01-24 CN CN202080022864.7A patent/CN113613656A/zh active Pending
- 2020-01-24 MX MX2021008834A patent/MX2021008834A/es unknown
- 2020-01-24 JP JP2021543165A patent/JP2022523045A/ja active Pending
- 2020-01-24 CA CA3126279A patent/CA3126279A1/en active Pending
- 2020-01-24 US US17/310,212 patent/US20220193076A1/en not_active Abandoned
- 2020-01-24 AU AU2020215551A patent/AU2020215551A1/en not_active Abandoned
- 2020-01-24 EP EP20708761.0A patent/EP3917533A1/en not_active Withdrawn
- 2020-01-24 SG SG11202107488PA patent/SG11202107488PA/en unknown
- 2020-01-27 AR ARP200100202A patent/AR119681A1/es not_active Application Discontinuation
-
2021
- 2021-07-14 IL IL284850A patent/IL284850A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523045A5 (https=) | ||
| CN111065411B (zh) | Pd-1抗体和vegfr抑制剂联合治疗小细胞肺癌的用途 | |
| RU2747788C2 (ru) | Комбинированная терапия ингибиторами notch и cdk4/6 для лечения рака | |
| TWI818120B (zh) | 藉由免疫檢查點阻礙藥與ｆｏｌｆｉｒｉｎｏｘ療法之併用的癌症治療 | |
| CN115845070A (zh) | 用notch和pd-1或pd-l1抑制剂的组合治疗 | |
| JP2019526595A5 (https=) | ||
| CA3146346A1 (en) | 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid for use in metastatic or advanced breast cancer patients | |
| JP2020523356A5 (https=) | ||
| JP2019508476A5 (https=) | ||
| TW201127384A (en) | Therapeutic combination comprising a Cdc7 inhibitor and an antineoplastic agent | |
| AU2020279289B2 (en) | Quinoline derivative used for combination treatment of small cell lung cancer | |
| TWI441639B (zh) | 用於治療卵巢癌之包含紫杉醇之組合 | |
| TWI719765B (zh) | 使用包含akt抑制劑、紫杉烷及pd-l1抑制劑之組合療法之乳癌治療 | |
| WO2017184086A1 (en) | Method of treating liver cancer | |
| TWI870592B (zh) | 使用免疫檢查點抑制劑抗體治療癌症之方法和組合 | |
| JP2021511344A5 (https=) | ||
| CN115429883A (zh) | 用于联合治疗的抗肿瘤药物组合物 | |
| CN112043831A (zh) | 用于联合治疗乳腺癌的喹啉类化合物 | |
| CN112043832A (zh) | 用于联合治疗胃癌的喹啉类化合物 | |
| JP2018522881A5 (https=) | ||
| Rhomberg et al. | Treatment of vascular soft tissue sarcomas with razoxane, vindesine, and radiation | |
| JP2024502465A5 (https=) | ||
| IL299028A (en) | Methods and compositions for treating chemotherapy-induced diarrhea | |
| HK40059348A (en) | Treatment of breast cancer using combination therapies comprising an akt inhibitor, a taxane, and a pd-l1 inhibitor | |
| TW202535407A (zh) | 治療癌症的方法 |